Stereotactic Body Radiotherapy: is less fractionation more effective in adrenal and renal malignant lesions? - Takeaways - MDSpire

Stereotactic Body Radiotherapy: is less fractionation more effective in adrenal and renal malignant lesions?

  • By

  • Daniel Rivas

  • Alejandro de la Torre-Luque

  • Elena Moreno-Olmedo

  • Paloma Moreno

  • Vladimir Suárez

  • Ana Serradilla

  • Gregorio Arregui

  • David Álvarez

  • Morena Sallabanda

  • Antonio Lazo

  • María Isabel Núñez

  • Escarlata López

  • July 24, 2024

  • 0 min

Share

  • 1

    The incidence of renal cell carcinoma and adrenal malignancies has increased, necessitating alternative treatments like stereotactic body radiation therapy (SBRT).

  • 2

    SBRT is a promising non-invasive treatment option for patients with renal cell carcinoma and adrenal malignancies who are inoperable or refuse surgery.

  • 3

    Despite the traditional view of renal cell carcinoma as radioresistant, recent findings suggest SBRT can be effective for these tumors.

  • 4

    The study analyzed 25 lesions in 23 patients, focusing on tumor-, patient-, and treatment-related factors influencing SBRT outcomes.

  • 5

    The median prescribed dose for SBRT was 60 Gy, with most patients receiving a Biological Equivalent Dose exceeding 100 Gy, indicating effective treatment.

Original Source(s)

Stereotactic Body Radiotherapy: is less fractionation more effective in adrenal and renal malignant lesions?

  • by Daniel Rivas, Alejandro de la Torre-Luque, Elena Moreno-Olmedo, Paloma Moreno, Vladimir Suárez, Ana Serradilla, Gregorio Arregui, David Álvarez, Morena Sallabanda, Antonio Lazo, María Isabel Núñez, Escarlata López

  • July 24, 2024

Related Content

2025 ESMO Prostate Cancer Highlights

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the prostate cancer clinical updates you need to know from ESMO 2025

  • November 17, 2025

  • 1 min
PSMA-PET/CT-based salvage elective nodal radiotherapy for lymph node recurrence following radical prostatectomy

Dana-Farber Research News 03.15.2026

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from February 16 - 28.

  • by

  • March 15, 2026

  • 21 min